Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting (vol 5, pg 1, 2019)

被引：0
|
作者：
Berger, T.
Brochet, B.
Brambilla, L.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL | 2020年 / 6卷 / 02期
关键词：
D O I：
10.1177/2055217320921146
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC
    Berger, T.
    Brochet, B.
    Brambilla, L.
    Giacomini, P. S.
    Montalban, X.
    Salgado, A. Vasco
    Su, R.
    Bretagne, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [2] Effectiveness of delayed-release dimethyl fumarate on clinical disease activity and patient-reported outcomes in patients with relapsing-remitting multiple sclerosis in the real-world setting: a multicentre, open-label study (PROTEC)
    Berger, T.
    Brochet, B.
    Confalonieri, P.
    Giacomini, P. S.
    Montalban, X.
    Vasco Salgado, A.
    Okwuokenye, M.
    Marantz, J. L.
    Mair, W.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 298 - 299
  • [3] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
  • [4] Effectiveness of Delayed-release Dimethyl Fumarate on Clinical Measures and Patient reported Outcomes in Newly Diagnosed and Other Early Relapsing-Remitting Multiple Sclerosis Patients: Subgroup Analysis of PROTEC
    Berger, Thomas
    Brochet, Bruno
    Confalonieri, Paolo
    Giacomini, Paul S.
    Montalban, Xavier
    Salgado, Antonio Vasco
    Okwuokenye, Macaulay
    Fay, Monica
    Bretagne, Adrien
    [J]. NEUROLOGY, 2017, 88
  • [5] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    [J]. NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [6] DELAYED-RELEASE DIMETHYL FUMARATE DEMONSTRATED NO DIFFERENCE IN CLINICAL OUTCOMES VERSUS FINGOLIMOD IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: RESULTS FROM THE REAL-WORLD EFFECT STUDY
    Sloane, Jacob
    Phillips, J. Theodore
    Calkwood, Jonathan
    Van der Walt, Anneke
    Min, Jinny
    Okwuokenye, Macaulay
    Taylor, Catherine
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E19 - E19
  • [7] Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-World EFFECT Study
    Sloane, Jacob
    Phillips, J. Theodore
    Calkwood, Jonathan
    Van der Walt, Anneke
    Min, Jinny
    Wu, Fan
    Taylor, Catherine
    [J]. NEUROLOGY, 2018, 90
  • [8] Delayed-release dimethyl fumarate demonstrated no difference in clinical outcomes versus fingolimod in patients with relapsing-remitting multiple sclerosis: results from the real-world EFFECT study
    Sloane, J.
    Phillips, J. T.
    Calkwood, J.
    Van der Walt, A.
    Min, J.
    Okwuokenye, M.
    Taylor, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 855 - 856
  • [9] Real-world clinical outcomes in relapsing-remitting multiple sclerosis patients who switch from natalizumab to delayed-release dimethyl fumarate: a multicenter, retrospective, observational study (STRATEGY)
    Cohan, S.
    Moses, H.
    Calkwood, J.
    Tornatore, C.
    Laganke, C.
    Smoot, K. E.
    Mann, M.
    Meka, V.
    Okwuokenye, M.
    Hotermans, C.
    Meltzer, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 262 - 262
  • [10] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis
    Michelle Allan
    Lindsay Grant
    [J]. Neurology and Therapy, 2020, 9 : 85 - 92
12345